Skip to main content
Erschienen in: Current Diabetes Reports 10/2015

01.10.2015 | Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure

verfasst von: Jost B. Jonas, Liang Xu, Jie Xu, Wen Bin Wei, Ya Xing Wang

Erschienen in: Current Diabetes Reports | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

In the Beijing Eye Study, a population-based study carried out in 2001, 2006, and 2011, prevalence of diabetic retinopathy (DR) was 2.9 ± 0.3 % (95 % confidence interval 2.3, 3.5) per individual in 2011. Correspondingly, only 1.1 % of blindness and 0.8 % of visual impairment were caused by DR in East Asia. As in other populations, prevalence, severity, and 10-year incidence of DR were associated with higher levels of HbA1c, higher blood glucose concentration, longer known duration of diabetes, lower educational level, and higher blood pressure. Interestingly, the presence, severity, and 10-year incidence of DR were additionally correlated with higher estimated cerebrospinal fluid pressure and shorter ocular length. Higher cerebrospinal fluid pressure may lead to higher retinal vein pressure and subsequently higher retinal capillary blood pressure increasing fluid and blood extravasation. Shorter axial length or hyperopia may be associated with higher intraocular concentration of cytokines. Aging of the society, improvements in medical infrastructure, and lifestyle changes may profoundly increase prevalence of, and burden by, DR in China in the future.
Literatur
1.
Zurück zum Zitat Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527–32.CrossRefPubMed Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527–32.CrossRefPubMed
2.
Zurück zum Zitat Mitchell P, Smith W, Wang JJ, et al. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology. 1998;105:406–11.CrossRefPubMed Mitchell P, Smith W, Wang JJ, et al. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology. 1998;105:406–11.CrossRefPubMed
3.
Zurück zum Zitat Dandona L, Dandona R, Naduvilath TJ, et al. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol. 1999;83:937–40.PubMedCentralCrossRefPubMed Dandona L, Dandona R, Naduvilath TJ, et al. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol. 1999;83:937–40.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Leske MC, Wu S, Hyman L, et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology. 1999;106:1893–1899. 10.CrossRefPubMed Leske MC, Wu S, Hyman L, et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology. 1999;106:1893–1899. 10.CrossRefPubMed
5.
6.
Zurück zum Zitat West SK, Klein R, Rodriguez J, et al. Proyecto VER. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24:1204–9.CrossRefPubMed West SK, Klein R, Rodriguez J, et al. Proyecto VER. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24:1204–9.CrossRefPubMed
7.
Zurück zum Zitat Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26:1731–7.CrossRefPubMed Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26:1731–7.CrossRefPubMed
8.
Zurück zum Zitat Varma R, Torres M, Peña F, et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology. 2004;111:1298–306.CrossRefPubMed Varma R, Torres M, Peña F, et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology. 2004;111:1298–306.CrossRefPubMed
9.
Zurück zum Zitat Kempen JH, O’Colmain BJ, Leske MC, et al. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–63.CrossRefPubMed Kempen JH, O’Colmain BJ, Leske MC, et al. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–63.CrossRefPubMed
10.
Zurück zum Zitat Rema M, Premkumar S, Anitha B, et al. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study. I Invest Ophthalmol Vis Sci. 2005;46:2328–33.CrossRefPubMed Rema M, Premkumar S, Anitha B, et al. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study. I Invest Ophthalmol Vis Sci. 2005;46:2328–33.CrossRefPubMed
11.
Zurück zum Zitat Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. AmJ Ophthalmol. 2006;141:446–55.CrossRef Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. AmJ Ophthalmol. 2006;141:446–55.CrossRef
12.
Zurück zum Zitat Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in an urban and rural area in Beijing: the Beijing Eye Study. Ophthalmology. 2006;113:1141.e1–3. Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in an urban and rural area in Beijing: the Beijing Eye Study. Ophthalmology. 2006;113:1141.e1–3.
13.
Zurück zum Zitat Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179–83.CrossRefPubMed Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179–83.CrossRefPubMed
14.
Zurück zum Zitat Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115:1869–75.CrossRefPubMed Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115:1869–75.CrossRefPubMed
15.
Zurück zum Zitat Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol. 2009;93:429–34.PubMed Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol. 2009;93:429–34.PubMed
16.
Zurück zum Zitat Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology. 2009;116:311–8.CrossRefPubMed Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology. 2009;116:311–8.CrossRefPubMed
17.
Zurück zum Zitat Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009;116:461–7.CrossRefPubMed Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009;116:461–7.CrossRefPubMed
19.
Zurück zum Zitat Zheng Y, Lamoureux EL, Lavanya R, et al. Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study. Ophthalmology. 2012;119:2119–24.CrossRefPubMed Zheng Y, Lamoureux EL, Lavanya R, et al. Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study. Ophthalmology. 2012;119:2119–24.CrossRefPubMed
20.
Zurück zum Zitat Ma XZ, Zhao JL, Ellwein LB, et al. Prevalence and causes of blindness and moderate and severe visual impairment among adults aged 50 years or above in Changji City of Xinjiang Uygur Autonomous Region: the China Nine-Province survey. Zhonghua Yan Ke Za Zhi. 2013;49:795–800. 11.PubMed Ma XZ, Zhao JL, Ellwein LB, et al. Prevalence and causes of blindness and moderate and severe visual impairment among adults aged 50 years or above in Changji City of Xinjiang Uygur Autonomous Region: the China Nine-Province survey. Zhonghua Yan Ke Za Zhi. 2013;49:795–800. 11.PubMed
21.
Zurück zum Zitat Pan CW, Cheung CY, Aung T, et al. Differential associations of myopia with major age-related eye diseases: the Singapore Indian Eye Study. Ophthalmology. 2013;120:284–91.CrossRefPubMed Pan CW, Cheung CY, Aung T, et al. Differential associations of myopia with major age-related eye diseases: the Singapore Indian Eye Study. Ophthalmology. 2013;120:284–91.CrossRefPubMed
22.
Zurück zum Zitat Jonas JB, Nangia V, Khare A, et al. Prevalence and associated factors of diabetic retinopathy in rural Central India. Diabetes Care. 2013;36:e69.PubMedCentralCrossRefPubMed Jonas JB, Nangia V, Khare A, et al. Prevalence and associated factors of diabetic retinopathy in rural Central India. Diabetes Care. 2013;36:e69.PubMedCentralCrossRefPubMed
23.•
Zurück zum Zitat Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1:e339–49. This meta-analysis describes the prevalence and causes for visual impairment and blindness worldwide in various world regions in 2010 as compared with 1990.CrossRefPubMed Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1:e339–49. This meta-analysis describes the prevalence and causes for visual impairment and blindness worldwide in various world regions in 2010 as compared with 1990.CrossRefPubMed
24.
Zurück zum Zitat Wong TY, Zheng Y, Jonas JB, et al. Prevalence and causes of vision loss in East Asia: 1990-2010. Br J Ophthalmol. 2014;98:599–604.CrossRefPubMed Wong TY, Zheng Y, Jonas JB, et al. Prevalence and causes of vision loss in East Asia: 1990-2010. Br J Ophthalmol. 2014;98:599–604.CrossRefPubMed
25.
Zurück zum Zitat Lamparter J, Raum P, Pfeiffer N, et al. Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study. J Diabetes Complicat. 2014;28:482–7.CrossRefPubMed Lamparter J, Raum P, Pfeiffer N, et al. Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study. J Diabetes Complicat. 2014;28:482–7.CrossRefPubMed
26.
Zurück zum Zitat Raman R, Ganesan S, Pal SS, et al. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care. 2014;2:e000005.PubMedCentralCrossRefPubMed Raman R, Ganesan S, Pal SS, et al. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care. 2014;2:e000005.PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Hautala N, Hannula V, Palosaari T, et al. Prevalence of diabetic retinopathy in young adults with type 1 diabetes since childhood: the Oulu cohort study of diabetic retinopathy. Acta Ophthalmol. 2014;92:749–52.CrossRefPubMed Hautala N, Hannula V, Palosaari T, et al. Prevalence of diabetic retinopathy in young adults with type 1 diabetes since childhood: the Oulu cohort study of diabetic retinopathy. Acta Ophthalmol. 2014;92:749–52.CrossRefPubMed
28.
Zurück zum Zitat Hu Y, Teng W, Liu L, et al. Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: a population-based cross-sectional study. PLoS One. 2015;10:e0121477.PubMedCentralCrossRefPubMed Hu Y, Teng W, Liu L, et al. Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: a population-based cross-sectional study. PLoS One. 2015;10:e0121477.PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Huang OS, Tay WT, Ong PG, et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol. 2015. doi:10.1136/bjophthalmol-2014-306492. Huang OS, Tay WT, Ong PG, et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol. 2015. doi:10.​1136/​bjophthalmol-2014-306492.
31.•
Zurück zum Zitat Yau JWY, Rogers SL, Kawasaki R, et al. The global prevalence and major risk factors of diabetic retinopathy and vision-threatening retinopathy in persons with diabetes. Diabetes Care. 2012;35:556–64. This meta-analysis presents prevalence of diabetic retinopathy in patients with diabetes worldwide.PubMedCentralCrossRefPubMed Yau JWY, Rogers SL, Kawasaki R, et al. The global prevalence and major risk factors of diabetic retinopathy and vision-threatening retinopathy in persons with diabetes. Diabetes Care. 2012;35:556–64. This meta-analysis presents prevalence of diabetic retinopathy in patients with diabetes worldwide.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12:346–54.CrossRefPubMed Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12:346–54.CrossRefPubMed
33.
Zurück zum Zitat Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on vision impairment in the year 2002. Bull World Health Organ. 2004;82:844–51.PubMedCentralPubMed Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on vision impairment in the year 2002. Bull World Health Organ. 2004;82:844–51.PubMedCentralPubMed
34.
Zurück zum Zitat Xu L, Li Y, Wang S, et al. Characteristics of highly myopic eyes. The Beijing Eye Study. Ophthalmology. 2007;114:121–126. 12.CrossRefPubMed Xu L, Li Y, Wang S, et al. Characteristics of highly myopic eyes. The Beijing Eye Study. Ophthalmology. 2007;114:121–126. 12.CrossRefPubMed
35.
Zurück zum Zitat Wang YX, Xu L, Yang H, et al. Prevalence of glaucoma in North China: the Beijing Eye Study. Am J Ophthalmol. 2010;150:917–24.CrossRefPubMed Wang YX, Xu L, Yang H, et al. Prevalence of glaucoma in North China: the Beijing Eye Study. Am J Ophthalmol. 2010;150:917–24.CrossRefPubMed
36.
Zurück zum Zitat Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806.
38.
Zurück zum Zitat Ren R, Wang N, Zhang X, et al. Cerebrospinal fluid pressure correlated with body mass index. Graefes Arch Clin Exp Ophthalmol. 2012;250:445–6.CrossRefPubMed Ren R, Wang N, Zhang X, et al. Cerebrospinal fluid pressure correlated with body mass index. Graefes Arch Clin Exp Ophthalmol. 2012;250:445–6.CrossRefPubMed
39.
Zurück zum Zitat Jonas JB, Nangia V, Wang N, et al. Trans-lamina cribrosa pressure difference and open-angle glaucoma: the Central India Eye and Medical Study. PLoS One. 2013;8:e82284.PubMedCentralCrossRefPubMed Jonas JB, Nangia V, Wang N, et al. Trans-lamina cribrosa pressure difference and open-angle glaucoma: the Central India Eye and Medical Study. PLoS One. 2013;8:e82284.PubMedCentralCrossRefPubMed
40.••
Zurück zum Zitat Jonas JB, Wang N, Yang D, et al. Facts and myths of cerebrospinal fluid pressure for the physiology of the eye. Prog Retin Eye Res. 2015;46:67–83. This review describes the potential role the cerebrospinal fluid pressure plays for the physiology and pathophysiology of the eye including the influence of the cerebrospinal fluid pressure on choroidal thickness, retinal vein diameter, trans-lamina cribrosa pressure difference and glaucomatous optic neuropathy, and diabetic retinopathy.CrossRefPubMed Jonas JB, Wang N, Yang D, et al. Facts and myths of cerebrospinal fluid pressure for the physiology of the eye. Prog Retin Eye Res. 2015;46:67–83. This review describes the potential role the cerebrospinal fluid pressure plays for the physiology and pathophysiology of the eye including the influence of the cerebrospinal fluid pressure on choroidal thickness, retinal vein diameter, trans-lamina cribrosa pressure difference and glaucomatous optic neuropathy, and diabetic retinopathy.CrossRefPubMed
41.
Zurück zum Zitat Berdahl JP, Fleischman D, Zaydlarova J, et al. Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2012;53:1422–7.PubMedCentralCrossRefPubMed Berdahl JP, Fleischman D, Zaydlarova J, et al. Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2012;53:1422–7.PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Jonas JB, Wang N, Xu J, et al. Diabetic retinopathy and estimated cerebrospinal fluid pressure. The Beijing Eye Study 2011. PLoS One. 2014;95:e96273.CrossRef Jonas JB, Wang N, Xu J, et al. Diabetic retinopathy and estimated cerebrospinal fluid pressure. The Beijing Eye Study 2011. PLoS One. 2014;95:e96273.CrossRef
43.•
Zurück zum Zitat Xu J, Xu L, Wang YX, et al. Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One. 2014;9:e111320. This longitudinal population-based study assessed the incidence of diabetic retinopathy in a 10-year period and its associated factors.PubMedCentralCrossRefPubMed Xu J, Xu L, Wang YX, et al. Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One. 2014;9:e111320. This longitudinal population-based study assessed the incidence of diabetic retinopathy in a 10-year period and its associated factors.PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Wang YX, Zhang JS, You QS, et al. Ocular diseases and 10-year mortality. The Beijing Eye Study 2001/2011. Acta Ophthalmol. 2014;92:e424–428.CrossRefPubMed Wang YX, Zhang JS, You QS, et al. Ocular diseases and 10-year mortality. The Beijing Eye Study 2001/2011. Acta Ophthalmol. 2014;92:e424–428.CrossRefPubMed
45.
Zurück zum Zitat Hsu WM, Cheng CY, Liu JH, et al. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2004;111:62–9.CrossRefPubMed Hsu WM, Cheng CY, Liu JH, et al. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2004;111:62–9.CrossRefPubMed
46.
Zurück zum Zitat Xu L, Jonas JB, Cui TT, et al. Beijing Eye Public Health Care Project. Ophthalmology. 2012;119:1167–74.CrossRefPubMed Xu L, Jonas JB, Cui TT, et al. Beijing Eye Public Health Care Project. Ophthalmology. 2012;119:1167–74.CrossRefPubMed
47.
Zurück zum Zitat Stevens G, White R, Flaxman SR, et al. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013;120:2377–2384. 13.CrossRefPubMed Stevens G, White R, Flaxman SR, et al. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013;120:2377–2384. 13.CrossRefPubMed
48.
Zurück zum Zitat Wild S, Roglic G, Green A, et al. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed Wild S, Roglic G, Green A, et al. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed
49.
Zurück zum Zitat Xu L, Xie X, Wang S, et al. Prevalence of diabetes mellitus in China. Exp Clin Endocrinol Diabetes. 2008;116:69–70.CrossRefPubMed Xu L, Xie X, Wang S, et al. Prevalence of diabetes mellitus in China. Exp Clin Endocrinol Diabetes. 2008;116:69–70.CrossRefPubMed
50.
Zurück zum Zitat Xie XW, Xu L, Jonas JB, Wang YX. Prevalence of diabetic retinopathy among subjects with known diabetes in China. The Beijing Eye Study. Eur J Ophthalmol. 2009;19:91–9.PubMed Xie XW, Xu L, Jonas JB, Wang YX. Prevalence of diabetic retinopathy among subjects with known diabetes in China. The Beijing Eye Study. Eur J Ophthalmol. 2009;19:91–9.PubMed
51.
Zurück zum Zitat Xu L, Xie X, Wang Y, et al. Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing Eye Study Eye. 2009;23:676–82.PubMed Xu L, Xie X, Wang Y, et al. Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing Eye Study Eye. 2009;23:676–82.PubMed
52.
Zurück zum Zitat Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22.PubMedCentralCrossRefPubMed Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22.PubMedCentralCrossRefPubMed
53.
Zurück zum Zitat Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.CrossRefPubMed Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.CrossRefPubMed
54.
Zurück zum Zitat Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed
55.
Zurück zum Zitat Bourne RRA, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol. 2014;98:629–38.CrossRefPubMed Bourne RRA, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol. 2014;98:629–38.CrossRefPubMed
56.
Zurück zum Zitat Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998;351:28–31.CrossRefPubMed Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998;351:28–31.CrossRefPubMed
57.
Zurück zum Zitat Varma R, Macias GL, Torres M, et al. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. Ophthalmology. 2007;114:1332–40.CrossRefPubMed Varma R, Macias GL, Torres M, et al. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. Ophthalmology. 2007;114:1332–40.CrossRefPubMed
58.
Zurück zum Zitat Sjølie AK, Klein R, Porta M, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 2008;372:1385–93.CrossRefPubMed Sjølie AK, Klein R, Porta M, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 2008;372:1385–93.CrossRefPubMed
59.
Zurück zum Zitat Tapp RJ, Tikellis G, Wong TY, et al. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care. 2008;31:1349–54.PubMedCentralCrossRefPubMed Tapp RJ, Tikellis G, Wong TY, et al. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care. 2008;31:1349–54.PubMedCentralCrossRefPubMed
60.
Zurück zum Zitat Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.PubMedCentralCrossRefPubMed Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.PubMedCentralCrossRefPubMed
61.
Zurück zum Zitat Xie X, Xu L, Yang H, et al. Frequency of diabetic retinopathy in the adult population in China: the Beijing Eye Study 2001. Int Ophthalmol. 2009;29:485–93.CrossRefPubMed Xie X, Xu L, Yang H, et al. Frequency of diabetic retinopathy in the adult population in China: the Beijing Eye Study 2001. Int Ophthalmol. 2009;29:485–93.CrossRefPubMed
62.
Zurück zum Zitat Xie XW, Xu L, Wang YX, et al. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graef Arch Clin Ophthalmol. 2008;246:1519–1526. 14.CrossRef Xie XW, Xu L, Wang YX, et al. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graef Arch Clin Ophthalmol. 2008;246:1519–1526. 14.CrossRef
63.
Zurück zum Zitat Jonas JB, Xu L, Xie XW, et al. Relationship between fasting glucose and retinopathy for diagnosis of diabetes. Retina. 2010;30:1223–7.CrossRefPubMed Jonas JB, Xu L, Xie XW, et al. Relationship between fasting glucose and retinopathy for diagnosis of diabetes. Retina. 2010;30:1223–7.CrossRefPubMed
64.
Zurück zum Zitat Tu Y, Xu L, Wen BW, et al. Progression of diabetic retinopathy. The Beijing Eye Study. Chin Med J. 2011;124:3635–40.PubMed Tu Y, Xu L, Wen BW, et al. Progression of diabetic retinopathy. The Beijing Eye Study. Chin Med J. 2011;124:3635–40.PubMed
65.
Zurück zum Zitat Park CY, Park SE, Bae JC, et al. Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants. Br J Ophthalmol. 2012;96:151–5.CrossRefPubMed Park CY, Park SE, Bae JC, et al. Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants. Br J Ophthalmol. 2012;96:151–5.CrossRefPubMed
66.
Zurück zum Zitat Henricsson M, Nyström L, Blohmé G, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003;26:349–54.CrossRefPubMed Henricsson M, Nyström L, Blohmé G, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003;26:349–54.CrossRefPubMed
67.
Zurück zum Zitat Leske MC, Wu SY, Hennis A, et al. Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology. 2003;110:941–7.CrossRefPubMed Leske MC, Wu SY, Hennis A, et al. Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology. 2003;110:941–7.CrossRefPubMed
68.
Zurück zum Zitat Cikamatana L, Mitchell P, Rochtchina E, et al. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye. 2007;21:465–71.PubMed Cikamatana L, Mitchell P, Rochtchina E, et al. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye. 2007;21:465–71.PubMed
69.
Zurück zum Zitat Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859–68.PubMedCentralCrossRefPubMed Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859–68.PubMedCentralCrossRefPubMed
70.
Zurück zum Zitat Grauslund J, Green A, Sjølie AK. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia. 2009;52:1829–35.CrossRefPubMed Grauslund J, Green A, Sjølie AK. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia. 2009;52:1829–35.CrossRefPubMed
71.
Zurück zum Zitat Varma R, Choudhury F, Klein R, et al. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2010;149:752–761.e1-3.PubMedCentralCrossRefPubMed Varma R, Choudhury F, Klein R, et al. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2010;149:752–761.e1-3.PubMedCentralCrossRefPubMed
72.
Zurück zum Zitat Kawasaki R, Tanaka S, Tanaka S, et al. Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia. 2011;54:2288–94.CrossRefPubMed Kawasaki R, Tanaka S, Tanaka S, et al. Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia. 2011;54:2288–94.CrossRefPubMed
73.
Zurück zum Zitat Jonas JB, Wang N, Wang S, Wang YX, You QS, Yang D, et al. Retinal vessel diameter and estimated cerebrospinal fluid pressure in arterial hypertension. The Beijing Eye Study. Am J Hypertension. 2014;27:1170–8.CrossRef Jonas JB, Wang N, Wang S, Wang YX, You QS, Yang D, et al. Retinal vessel diameter and estimated cerebrospinal fluid pressure in arterial hypertension. The Beijing Eye Study. Am J Hypertension. 2014;27:1170–8.CrossRef
74.
Zurück zum Zitat Jonas JB, Wang N, Wang YX, et al. Incident retinal vein occlusions and estimated cerebrospinal fluid pressure. The Beijing Eye Study. Acta Ophthalmol. 2015. doi:10.1111/aos.12575. Jonas JB, Wang N, Wang YX, et al. Incident retinal vein occlusions and estimated cerebrospinal fluid pressure. The Beijing Eye Study. Acta Ophthalmol. 2015. doi:10.​1111/​aos.​12575.
75.
Zurück zum Zitat Klein R, Klein BE, Moss SE, et al. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2004;122:76–83.CrossRefPubMed Klein R, Klein BE, Moss SE, et al. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2004;122:76–83.CrossRefPubMed
76.
Zurück zum Zitat Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in glaucoma. A prospective study. Ophthalmology. 2010;117:259–266. 15.CrossRefPubMed Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in glaucoma. A prospective study. Ophthalmology. 2010;117:259–266. 15.CrossRefPubMed
77.
Zurück zum Zitat Jonas JB, Ritch R, Panda-Jonas S. Cerebrospinal fluid pressure in the pathogenesis of glaucoma. In: Giacinto Bagetta and Carlo Nucci: New trends in basic and clinical research of glaucoma: a neurodegenerative disease of the visual system. Prog Brain Res. 2015. Jonas JB, Ritch R, Panda-Jonas S. Cerebrospinal fluid pressure in the pathogenesis of glaucoma. In: Giacinto Bagetta and Carlo Nucci: New trends in basic and clinical research of glaucoma: a neurodegenerative disease of the visual system. Prog Brain Res. 2015.
78.
Zurück zum Zitat Jonas JB, Wang N, Wang YX, et al. Subfoveal choroidal thickness and cerebrospinal fluid pressure. The Beijing Eye Study 2011. Invest Ophthalmol Vis Sci. 2014;55:1292–8.CrossRefPubMed Jonas JB, Wang N, Wang YX, et al. Subfoveal choroidal thickness and cerebrospinal fluid pressure. The Beijing Eye Study 2011. Invest Ophthalmol Vis Sci. 2014;55:1292–8.CrossRefPubMed
79.
80.
Zurück zum Zitat Jonas JB, Harder B. Ophthalmodynamometric estimation of cerebrospinal fluid pressure in pseudotumor cerebri. Br J Ophthalmol. 2003;87:361–2.CrossRef Jonas JB, Harder B. Ophthalmodynamometric estimation of cerebrospinal fluid pressure in pseudotumor cerebri. Br J Ophthalmol. 2003;87:361–2.CrossRef
81.
Zurück zum Zitat Jonas JB, Pfeil K, Chatzikonstantinou A, et al. Ophthalmodynamometric measurement of central retinal vein pressure as surrogate of intracranial pressure in idiopathic intracranial hypertension. Graef Arch Clin Ophthalmol. 2008;246:1059–60.CrossRef Jonas JB, Pfeil K, Chatzikonstantinou A, et al. Ophthalmodynamometric measurement of central retinal vein pressure as surrogate of intracranial pressure in idiopathic intracranial hypertension. Graef Arch Clin Ophthalmol. 2008;246:1059–60.CrossRef
82.
Zurück zum Zitat Jonas JB, Harder B. Ophthalmodynamometric differences between ischemic versus non-ischemic retinal vein occlusion. Am J Ophthamol. 2007;143:112–6.CrossRef Jonas JB, Harder B. Ophthalmodynamometric differences between ischemic versus non-ischemic retinal vein occlusion. Am J Ophthamol. 2007;143:112–6.CrossRef
83.
Zurück zum Zitat Medele RJ, Stummer W, Mueller AJ, et al. Terson’s syndrome in subarachnoid hemorrhage and severe brain injury accompanied by acutely raised intracranial pressure. J Neurosurg. 1998;88:851–4.CrossRefPubMed Medele RJ, Stummer W, Mueller AJ, et al. Terson’s syndrome in subarachnoid hemorrhage and severe brain injury accompanied by acutely raised intracranial pressure. J Neurosurg. 1998;88:851–4.CrossRefPubMed
84.
Zurück zum Zitat De Maeyer K, Van Ginderdeuren R, Postelmans L, et al. Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy. Br J Ophthalmol. 2007;91:869–72.PubMedCentralCrossRefPubMed De Maeyer K, Van Ginderdeuren R, Postelmans L, et al. Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy. Br J Ophthalmol. 2007;91:869–72.PubMedCentralCrossRefPubMed
85.
Zurück zum Zitat Stodtmeister R, Ventzke S, Spoerl E, et al. Enhanced pressure in the central retinal vein decreases the perfusion pressure in the prelaminar region of the optic nerve head. Invest Ophthalmol Vis Sci. 2013;54:4698–704.CrossRefPubMed Stodtmeister R, Ventzke S, Spoerl E, et al. Enhanced pressure in the central retinal vein decreases the perfusion pressure in the prelaminar region of the optic nerve head. Invest Ophthalmol Vis Sci. 2013;54:4698–704.CrossRefPubMed
86.
Zurück zum Zitat Pierro L, Brancato R, Robino X, et al. Axial length in patients with diabetes. Retina. 1999;19:401–4.CrossRefPubMed Pierro L, Brancato R, Robino X, et al. Axial length in patients with diabetes. Retina. 1999;19:401–4.CrossRefPubMed
87.
Zurück zum Zitat Lim LS, Lamoureux E, Saw SM, et al. Are myopic eyes less likely to have diabetic retinopathy? Ophthalmology. 2010;117:524–30.CrossRefPubMed Lim LS, Lamoureux E, Saw SM, et al. Are myopic eyes less likely to have diabetic retinopathy? Ophthalmology. 2010;117:524–30.CrossRefPubMed
88.
Zurück zum Zitat Man RE, Sasongko MB, Sanmugasundram S, et al. Longer axial length is protective of diabetic retinopathy and macular edema. Ophthalmology. 2012;119:1754–9.CrossRefPubMed Man RE, Sasongko MB, Sanmugasundram S, et al. Longer axial length is protective of diabetic retinopathy and macular edema. Ophthalmology. 2012;119:1754–9.CrossRefPubMed
89.
Zurück zum Zitat Xu L, Li Y, Zheng Y, et al. Associated factors for age-related maculopathy in the adult population in China. The Beijing Eye Study. Br J Ophthalmol. 2006;90:1087–90.PubMedCentralCrossRefPubMed Xu L, Li Y, Zheng Y, et al. Associated factors for age-related maculopathy in the adult population in China. The Beijing Eye Study. Br J Ophthalmol. 2006;90:1087–90.PubMedCentralCrossRefPubMed
90.
Zurück zum Zitat Pan CW, Ikram MK, Cheung CY, et al. Refractive errors and age-related macular degeneration: a systematic review and meta-analysis. Ophthalmology. 2013;120:2058–65.CrossRefPubMed Pan CW, Ikram MK, Cheung CY, et al. Refractive errors and age-related macular degeneration: a systematic review and meta-analysis. Ophthalmology. 2013;120:2058–65.CrossRefPubMed
91.
Zurück zum Zitat Jonas JB, Tao Y, Neumaier M, et al. VEGF and refractive error. Ophthalmology. 2010;117:2234–5.CrossRefPubMed Jonas JB, Tao Y, Neumaier M, et al. VEGF and refractive error. Ophthalmology. 2010;117:2234–5.CrossRefPubMed
92.•
Zurück zum Zitat Zhu D, Yang DY, Guo YY, et al. Intracameral interleukin 1β, 6, 8, 10, 12p, tumor necrosis factor α and vascular endothelial growth factor and axial length in patients with cataract. PLoS One. 2015;10:e0117777. 16. This clinical interventional study describes a higher intraocular concentration of vascular endothelial growth factor in eyes with shorter axial length. It may explain the association between a higher prevalence of diabetic retinopathy and shorter ocular axial length. Zhu D, Yang DY, Guo YY, et al. Intracameral interleukin 1β, 6, 8, 10, 12p, tumor necrosis factor α and vascular endothelial growth factor and axial length in patients with cataract. PLoS One. 2015;10:e0117777. 16. This clinical interventional study describes a higher intraocular concentration of vascular endothelial growth factor in eyes with shorter axial length. It may explain the association between a higher prevalence of diabetic retinopathy and shorter ocular axial length.
93.
Zurück zum Zitat Hu Q, Liu G, Deng Q, et al. Intravitreal vascular endothelial growth factor concentration and axial length. Retina. 2015;35:435–9.CrossRefPubMed Hu Q, Liu G, Deng Q, et al. Intravitreal vascular endothelial growth factor concentration and axial length. Retina. 2015;35:435–9.CrossRefPubMed
94.
Zurück zum Zitat Xu L, Wang YX, Jonas JB. Level of education associated with ophthalmic diseases. The Beijing Eye Study. Graefes Arch Clin Exp Ophthalmol. 2010;248:49–57.CrossRefPubMed Xu L, Wang YX, Jonas JB. Level of education associated with ophthalmic diseases. The Beijing Eye Study. Graefes Arch Clin Exp Ophthalmol. 2010;248:49–57.CrossRefPubMed
Metadaten
Titel
Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure
verfasst von
Jost B. Jonas
Liang Xu
Jie Xu
Wen Bin Wei
Ya Xing Wang
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 10/2015
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0649-7

Weitere Artikel der Ausgabe 10/2015

Current Diabetes Reports 10/2015 Zur Ausgabe

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Vascular Smooth Muscle as a Target for Novel Therapeutics

Lifestyle Management to Reduce Diabetes\/Cardiovascular Risk (E Mayer-Davis and C Shay, Section Editors)

Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion

Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Novel Therapies in Development for Diabetic Macular Edema

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.